The massive pharmacy benefit manager plans to stop requiring coverage reauthorizations for roughly 80 drugs used to treat ...
The PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid.
The PBM plans to stop requiring coverage authorization for about 80 drugs, including Vertex’s cystic fibrosis medicines and ...
Optum Rx will increase reimbursements to pharmacies for brand-name drugs and cut them for generics. Optum Rx said the new pharmacy payment models are in response to price increases set by brand name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback